Vita 34 AG Stock
Price
Target price
€5.85
€5.85
-1.680%
-
-1.680%
-
01.10.25 / Tradegate
WKN: A0BL84 / Name: Vita 34 / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vita 34 AG Stock
A loss of -1.680% shows a downward development for Vita 34 AG.
Criterium "Market Position" is seen as the biggest plus for Vita 34 AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vita 34 AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vita 34 AG | -1.680% | 0.847% | -18.493% | 31.057% | 44.417% | -13.265% | -52.590% |
| Mediclin AG | -3.180% | 2.027% | -1.948% | 30.172% | 26.891% | 0.667% | -21.762% |
| M1 Kliniken AG | -2.240% | 1.420% | 5.155% | -15.503% | -14.234% | 257.000% | 57.269% |
| Addus Homecare Corp. | - | 3.684% | 1.546% | -14.348% | -17.917% | 3.684% | 24.684% |
News
EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland
EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland
EQS-News: FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future
EQS-News: FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future
EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek
EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek